Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children

International Journal of Obesity

Volumn 27, Issue 1, 2003, Pages 13-18

  Valle, M ^a   Gascon F ^a   Martos, R ^b   Bermudo, F ^a   Ceballos, P ^a   Suanes, A ^c  

^a Valle de los Pedroches Hospital   (Spain)

^b Basic Health Zone of Pozoblanco   (Spain)

^c Basic Health Zone of Poniente Norte   (Spain)

Author keywords

Cardiovascular risk; Children; Leptin; Metabolic syndrome; Obesity

Indexed keywords

APOLIPOPROTEIN A; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX HORMONE BINDING GLOBULIN; TISSUE PLASMINOGEN ACTIVATOR;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PREDICTION; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; INSULIN; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037260480     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802154     Document Type: Article

References (38)

1. Turner RC. The role of obesity in diabetes. Int J Obes Relat Metab Disord 1992; 16(Suppl 2): S43-S46.
2. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993; 119: 655-660.
3. Kissebah AH, Freedman DS, Peiris AN. Health risks of obesity. Med Clin North Am 1989; 73: 111-138.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
5. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al. Serum immunoreactive-leptin concentrations in normal weight and obese humans. New Engl J Med 1996; 334: 292-295.
6. Monti LD, Brambilla P, Stefani I, Caumo A, Magni E, Poma R, Tomasini L, Agostini G, Galli-Kienle M, Cobelli C et al. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Diabetologia 1995; 38: 739-747.
7. Caprio S, Bronson M, Sherwin RS, Rife E, Tamborlane WV. Coexistence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996; 39: 1489-1497.
8. Csabi G, Torok K, Jeges S, Molnar D. Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000; 159: 91-94.
9. Asayama K, Hayashibe H, Dobashi K, Uchida N, Kawada Y, Nakazawa S. Relationships between biochemical abnormalities and anthropometric indices of overweight, adiposity and body fat distribution in Japanese elementary school children. Int J Obes Relat Metab Disord 1995; 19: 253-259.
10. Wattigney WA, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study. Arch Intern Med 1991; 151: 2017-2022.
11. Tokunaga K, Ishikawa K, Sudo H, Matsuzawa Y, Yamamoto A, Tarui S. Serum lipoprotein profile in Japanese obese children. Int J Obes 1982; 6: 399-404.
12. Gascón F, Valle M, Martos R, Ruz FJ, Ríos R, Montilla P, Cañete R. Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. Eur J Endocrinol 2000; 143: 85-89.
13. Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Ríos R, Cañete R. Infantile obesity: a situation of atherothrombotic risk? Metabolism 2000; 49: 672-675.
14. Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Morales R, Cañete R. Metabolic cardiovascular syndrome in obese pre-pubertal children: the role of high fasting insulin levels. Metabolism 2002; 51: 423-428.
15. Kamoda T, Saitoh H, Nakahara S, Izumi I, Hirano T, Matsui A. Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin Endocrinol 1998; 49: 385-389.
16. Zimonet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 1996; 313: 965-969.
17. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
18. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effects of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637-4641.
19. Walder K, Filippis A, Clark S, Zimmet P, Collier GR. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol 1997; 155: R5-7.
20. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313-316.
21. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabetic Med 1997; 14: 200-208.
22. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928-933.
23. Zimmat P, Boyko EJ, Collier GR, de Courten M. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann NY Acad Sci 1999; 892: 25-44.
24. Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfutzner A. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999; 48: 677-680.
25. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052-3056.
26. Hernández M, Castell J, Narvaiza JL, Rincón JM, Ruiz E, Sánchez E. Curvas y tablas de crecimiento. Instituto de lnvestigación sobre Crecimiento y Desarrollo. Funcación Faustino Orbegozo. Madrid, Ed. Garsi 1988.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
28. Krotkiewski M, Björntorp P, Sjöstrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150-1162.
29. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L, Muggeo M. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20: 975-989.
30. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
31. Moussa MA, Shaltout AA, Nkansa-Dwamena D, Mourad M, Al-Sheikh N, Agha N, Galal DO. Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children. Metabolism 1998; 47: 420-424.
32. Steinberger J. Insulin resistance and cardiovascular risk in the pediatric patient. Prog Pediatr Cardiol 2001; 12: 169-175.
33. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409-418.
34. De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L, Giorgino R. Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism 1999; 48: 960-964.
35. Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49: 890-895.
36. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
37. Sheu WH, Lee WJ, Chen YT. High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289-1295.
38. Uckaya G, Ozata M, Sommez A, Kinalp C, Eyileten T, Bingol N, Koc B, Kocabalkan F, Ozdemir IC. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension. Horm Metab Res 1999; 31: 435-438.